|
SLC29A1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.383540E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.702300E-02 |
| Normal-vs-Stage2 |
2.518100E-03 |
| Normal-vs-Stage3 |
2.975000E-01 |
| Normal-vs-Stage4 |
2.126100E-02 |
| Stage1-vs-Stage2 |
1.810630E-01 |
| Stage1-vs-Stage3 |
9.045400E-01 |
| Stage1-vs-Stage4 |
5.317000E-01 |
| Stage2-vs-Stage3 |
3.637600E-01 |
| Stage2-vs-Stage4 |
4.815000E-01 |
| Stage3-vs-Stage4 |
6.601800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.820500E-03 |
| Normal-vs-AfricanAmerican |
5.258400E-01 |
| Normal-vs-Asian |
7.635600E-01 |
| Caucasian-vs-AfricanAmerican |
1.335560E-02 |
| Caucasian-vs-Asian |
3.634000E-01 |
| AfricanAmerican-vs-Asian |
9.382000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.975500E-02 |
| Normal-vs-Female |
9.243600E-03 |
| Male-vs-Female |
5.671400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.667800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.282200E-02 |
| Normal-vs-Age(61-80Yrs) |
5.464700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.955370E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.091800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.038000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.211030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.001200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.049900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.072200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.040010E-01 |
| Normal-vs-Grade 2 |
3.033700E-02 |
| Normal-vs-Grade 3 |
7.950000E-02 |
| Normal-vs-Grade 4 |
6.879200E-03 |
| Grade 1-vs-Grade 2 |
7.043000E-01 |
| Grade 1-vs-Grade 3 |
6.342400E-01 |
| Grade 1-vs-Grade 4 |
9.301000E-01 |
| Grade 2-vs-Grade 3 |
9.857600E-01 |
| Grade 2-vs-Grade 4 |
4.622200E-01 |
| Grade 3-vs-Grade 4 |
5.833000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.14009999955201E-07 |
| Normal-vs-ccB subtype |
9.964800E-01 |
| ccA subtype-vs-ccB subtype |
6.208000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.536150E-01 |
| Normal-vs-N1 |
2.092400E-01 |
| N0-vs-N1 |
7.636600E-01 |
|
|
